Northeast Pharmaceutical Group Co., Ltd. Stock: price and insider trades · China
东北制药
No insider purchase over the last 90 days. The latest, by 郑伟, was filed 31 May 2022.
Northeast Pharmaceutical Group Co., Ltd.: what insiders have been doing
Northeast Pharmaceutical Group Co., Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). Over the twelve months to 7 November 2026, 6 filings were filed, from 1 insider.
All open-market trades in the period are sales: 6 sales worth €122k, by 1 insider, with no purchase on record. One trade stands out by size: a sale of €42k from 郭建民, disclosed on 8 October 2026.
With 6 filings in twelve months, the company is more active than the median of 2 filings across the 522 companies we follow on the same exchange. The full history, which starts in 2021, counts 9 purchases against 6 sales.
The median gap between trade and publication is zero days: most filings appear on the same day. That lag is the time during which only the insider knows about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -0.2%Entry CN¥5.33 · Close at T+365 CN¥5.32
- +2.6%Entry CN¥5.35 · Close at T+365 CN¥5.49
- +36.6%Entry CN¥5.16 · Close at T+365 CN¥7.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 5,000 shares@ CN¥36.00531.2% of flowA股XSHESZSE:273000001721832300
- 10,000 shares@ CN¥35.91692.5% of flowA股XSHESZSE:273000001716813500
- 60,000 shares@ CN¥35.876215.5% of flowA股XSHESZSE:273000001704892640
- 30,000 shares@ CN¥36.54239.3% of flowA股XSHESZSE:273000001694628060
- 65,000 shares@ CN¥36.025421.9% of flowA股XSHESZSE:273000001645735580
- 20,000 shares@ CN¥36.26498.4% of flowA股XSHESZSE:273000001641258140
- 36,000 shares54.1% of flowA股XSHESZSE:173000005558279000Canonical exit: 29 Aug 2022 (T+90)
- 100 shares0.5% of flowA股XSHESZSE:173000005553620700Canonical exit: 23 Aug 2022 (T+90)
- 11,000 shares17.2% of flowA股XSHESZSE:173000005542938500Canonical exit: 18 Aug 2022 (T+90)
- 18,600 shares28.8% of flowA股XSHESZSE:173000005539586050Canonical exit: 17 Aug 2022 (T+90)
- 19,700 shares99.5% of flowA股XSHESZSE:173000005491264160Canonical exit: 27 Jul 2022 (T+90)
- 50,000 shares26.5% of flowA股XSHESZSE:173000005173966850Canonical exit: 15 Mar 2022 (T+90)
- 30,000 shares15.8% of flowA股XSHESZSE:173000005167089500Canonical exit: 13 Mar 2022 (T+90)
- 3,200 shares100.0% of flowA股XSHESZSE:173000005118990720Canonical exit: 27 Feb 2022 (T+90)
- 110,000 shares57.7% of flowA股XSHESZSE:173000005118990820Canonical exit: 27 Feb 2022 (T+90)
15 of 15 declarations
About Northeast Pharmaceutical Group Co., Ltd.
Northeast Pharmaceutical is a Chinese company specializing in the manufacturing of pharmaceutical products. It is listed on the XSHE market and focuses on the development of medications for various treatments.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
